FindTrial
Sign In

Preventing Breast Cancer Recurrence after surgery

Effects of Perioperative Stratagem on Biobehavioural Profile of Breast Cancer: A Prospective Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022784
Enrollment
192
Registered
2020-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Total Intravenous Anaesthesia: Propofol will be used for maintenance of anaesthesia. it will be given at Induction and Maintenance Phase of anaesthesia. total dose given will be 2 mg/kg

Sponsors

AIIMS Rishikesh
Lead Sponsor
Uttarakhand Council of Science and Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Primary breast cancer without known metastasis scheduled for unilateral MODIFIED RADICLE MASTECTOMIES

Exclusion criteria

Exclusion criteria: Previous surgery for breast cancer Inflammatory breast cancer Free flap reconstruction ASA Status � 4 Other coexistent cancer

Design outcomes

Primary

MeasureTime frame
To study perioperative delta change in Vascular Endothelial Growth FactorTimepoint: 24 HOURS BEFORE SURGERY 24 HOURS AFTER SURGERY—

Secondary

MeasureTime frame
To study perioperative delta change in Interleukin 6 & Tumor Necrosis factor Ã?± Timepoint: 24 HOURS BEFORE SURGERY 24 HOURS AFTER SURGERY—

Countries

India

Contacts

Public ContactNishith Govil

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

nishithgovil@rediffmail.com08126101759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 19, 2026